Introduction
M esenchymal stem cells (MSCs) hold great promise for tissue bioengineering and regenerative medicine. MSCs are adherent marrow stromal cells that can self-renew and differentiate into osteogenic, chondrogenic, adipogenic, and myogenic lineages [1] [2] [3] [4] [5] . Although primarily residing in within the bone marrow compartment [5] [6] [7] , MSCs have been isolated from periosteum, trabecular bone, adipose tissue, synovium, skeletal muscle, and deciduous teeth [8] . MSCs represent a very small fraction (e.g., 0.001-0.01%) of the total population of nucleated cells in the marrow [3] . Currently, the biologic properties of MSCs, specifi cally with respect to their existence in the adult organism and postulation of their biological niche, are not well understood. It is essential to understand the molecular mechanisms that govern the stem cell potential and lineage-specifi c differentiation of MSCs because MSCs without directed differentiation may become tumorigenic in vivo [9, 10] .
Several signaling pathways have been implicated in regulating stem cell self-renewal and lineage commitment [11] [12] [13] [14] [15] [16] . Bone morphogenetic proteins (BMPs) play an important role in regulating cell proliferation and differentiation during development [17, 18] and have been shown to play an important role in stem cell biology [19, 20] . BMPs belong to the TGF-β superfamily and consist of at least 15 members in humans [17, 18, 21, 22] . Genetic disruptions of BMPs have resulted in various skeletal and extraskeletal abnormalities during development [21, 23] . BMPs fulfi ll their signaling activity by interacting with the heterodimeric complex of two transmembrane serine/threonine kinase receptors, BMPR type I and BMPR type II [17] . The activated receptor kinases phosphorylate the transcription factors Smads 1, 5, or 8, which in turn form a heterodimeric complex with Smad4 in the nucleus and activate the expression of target genes in concert with other coactivators [17] .
Although not well understood, BMPs play an important role in regulating osteoblast differentiation and subsequent bone formation [22, [24] [25] [26] [27] . We have demonstrated that several BMPs are potent inducers of osteogenesis of MSCs [27] [28] [29] [30] [31] [32] , and that osteogenic BMPs (e.g., BMP-2, BMP-6, and BMP-9) regulate a distinct set of downstream targets that may play a role in regulating BMP-induced osteoblast differentiation [27, [30] [31] [32] [33] . BMP-2, BMP-4, and BMP-7, in coordination with other signaling molecules or supplementary cofactors, have been shown to promote preadipocyte differentiation [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] . However, the biological effects of BMPs on multiple lineage commitment and terminal differentiation of MSCs have not comprehensively analyzed.
In this study, using a well-characterized mesenchymal stem cell line C3H10T1/2 [47] and primary mesenchymal progenitor cells, we conducted a comprehensive analysis of 14 types of BMPs for their ability to induce lineage-specifi c differentiation of MSCs. BMPs were shown to exhibit distinct abilities to regulate expression of the master regulators of four different lineages. When the osteogenic and adipogenic lineages were further analyzed, BMP-2, -4, -6, -7, and -9 were shown to effectively induce both adipogenic and osteogenic differentiation of MSCs in vitro and in vivo, although the commitment of MSCs to osteoblast or adipogenic lineage was shown to be mutually exclusive. Overexpression of Runx2 synergizes with BMP-induced osteogenic differentiation, while exerting not detectable effects on adipogenic differentiation. However, overexpression of PPARγ2 promotes both osteogenic and adipogenic differentiation in vitro and in vivo. Conversely, knockdown or deletion of PPARγ2 not only inhibited adipogenic differentiation, but also diminished BMP-induced ossifi cation, suggesting that PPARγ2 may also play an important role in osteogenic differentiation. Taken together, fi ndings from our in vitro and in vivo studies suggest that BMPs may play an important role in regulating multilineage commitment and terminal differentiation of MSCs. Understanding the regulatory mechanisms behind BMP-regulated lineage divergence of MSC differentiation may lead to the development of novel therapeutic strategies for human disorders (such as osteoporosis and obesity) and for regenerative medicine.
Materials and Methods

Cell culture and chemicals
HEK293 and C3H10T1/2 cell lines were obtained from the ATCC (Manassas, VA), and were maintained in complete DMEM and Basal Medium Eagle, respectively. Unless indicated otherwise, all chemicals were purchased from Sigma-Aldrich or Fisher Scientifi c.
Adenoviral vectors expressing BMPs, PPARγ2, and Runx2
Recombinant adenoviruses expressing the 14 types of human BMPs (i.e., AdBMPs) were generated as previously described [28, 29, 48] . The coding regions for mouse PPARγ2 and Runx2 were amplifi ed by PCR and subcloned into a shuttle vector for recombinant adenovirus generation using the AdEasy system [48, 49] . The resultant vectors are designated as AdPPARγ2 and AdRunx2. An analogous adenovirus expressing GFP only (i.e., AdGFP) was used as a control [49] [50] [51] .
Quantitative real-time PCR (qPCR) analysis
The qPCR was carried out as described [31] [32] [33] . Ten micrograms of total RNA were used to generate cDNA templates by reverse transcription with hexamer and Superscript II reverse transcriptase (Invitrogen). The fi rst strand cDNA products were further diluted 5-to 10-fold and used as qPCR templates. The qPCR primers (Supplementary Table 1;  Supplementary Table 1 is available online at http://www. liebertpub.com/scd) were 18-mers, designed by using the Primer3 program, http://frodo.wi.mit.edu/cgi-bin/primer3/ primer3_www.cgi, to amplify the 3'-end (approximately 120 bps) of the mouse Runx2, Sox9, MyoD, or PPARγ2 genes. SYBR Green-based qPCR analysis was carried out by using the Opticon DNA Engine (M J Research). The specifi city of each qPCR reaction was verifi ed by melting curve analysis and further confi rmed by resolving the PCR products on 1.5% agarose gels. Ten-fold serially diluted pUC19 was used as a standard. Triplicate reactions were carried out for each sample. All samples were normalized by the expression level of GAPDH.
Alkaline phosphatase activity
Alkaline phosphatase activity was assessed by the colorimetric assay and/or histochemical staining assay as previously described [28] [29] [30] [31] [32] [33] .
Construction and verifi cation of Runx2 and PPARγ2 knockdown vectors
We used our recently developed pSOS system to select and validate effi cacious short interfering double-stranded RNA (siRNA) target sites of mouse Runx2 and PPARγ2 [52] . Briefl y, we designed four pairs of oligonucleotides Dawley). Five weeks after implantation, animals were sacrifi ced and the implantation sites were retrieved for microCT analysis and histologic evaluation and other stains.
Hematoxylin and Eosin, Masson's Trichrome, and Alcian Blue staining
Retrieved tissues were decalcifi ed, fi xed in 10% formalin overnight, and embedded in paraffi n. Serial sections of the embedded specimens were stained with hematoxylin and eosin (H&E). Masson's Trichrome stain was carried out as described [29] . Deparaffi nized and rehydrated sections were stained with 1% Alcian Blue pH 2.5.
Oil Red-O staining
Decalcifi ed and paraformaldehyde fi xed tissues were subjected to frozen sectioning. The sections were rinsed with PBS, water and ethanol, and then stained with freshly prepared Oil Red-O solution (six parts saturated Oil Red-O dye in isopropanol plus four parts water) at 37°C for 15 min, followed by washing with 70% ethanol and PBS.
Transmission electron microscopy analysis
For transmission electron microscopy, MSCs were infected with AdGFP or AdBMPs for 7 or 14 days, and fi xed with 0.5% glutaraldehyde (in 0.1 M sodium phosphate buffer, pH 7.4) at 4°C for 30 min. The fi xed cells were collected by using cell scrappers followed by a brief centrifugation. The cell pellets were washed with 0.1 M sodium barbital buffer, pH 9.4, 2-3 times, and incubated in alkaline phosphatase (ALP) substrate solution (0.1 M barbital buffer, pH 9.4, 0.1 M β-glycerophosphate, 0.5 M MgCl 2 , and 0.2 M CaCl 2 ) at room temperature for 60 min, followed by washing with 0.1 M sodium barbital buffer, pH 9.4 or PBS. The cell pellets were then incubated in precold 0.05 M lead nitrate for 4 min at room temperature and washed extensively with PBS. The cell pellets were fi xed for additional 2 h in 2.5% glutaraldehyde, and postfi xed for 2 h with 1% osmium tetroxide. The cell pellets were dehydrated in an ascending ethanol series washes and embedded in Epon 812. Serial ultrathin sections were stained with uranyl acetate and lead citrate, and then examined using a Zeiss 900 electron microscope. Magnifi cations, 7,000× to 12,000×.
MicroCT analysis
The cone-beam micro-CT system used for acquiring mouse data consists of a microfocal X-ray source, an orthogonally-mounted rotary stage with object holder, and a CsI-coupled CMOS detector. The microfocal X-ray source (MX-20, Faxitron, USA) comprises of a tungsten anode with beryllium exit window, and it has a focal spot of 20 μm and was operated at 28 KeV. The 14-bit digital camera (Bioptics, USA) includes a CsI scintillator plate and a 2048 × 1024 array of CMOS thin-fi lm transistors and photodiodes with a pixel size of 50 μm. The new developed back projectionfi ltration (BPF) algorithm with a unit appodization function was used for reconstructing volumetric mouse images from the acquired cone-beam data. Volume-rendered views were generated with opacity-weighted compositing containing siRNA target sites for mouse Runx2 or PPARγ2 using Dharmacon's siDESIGN program (Supplementary Table 1 ). The oligo pairs were annealed and subcloned into the Sfi I site of pSOS, resulting in pSOS-simRunx2 or pSOSsimPPARγ2. To assess the knockdown effi ciency, we further subcloned the coding regions of mouse Runx2 and PPARγ2 into the pSOS-simRunx2 and pSOS-simPPARγ2, resulting in pSOS-simRunx2-WT and pSOS-simPPARγ2-WT, respectively. The pSOS-simRunx2-WT and pSOS-simPPRAγ2-WT were transfected into HEK-293 cells, and GFP signal levels were used to assess the silencing effi ciency of different siRNA target sites [52] . Authenticity of PCR amplifi ed sequences and the oligonucleotide cassettes were verifi ed by DNA sequencing. Cloning and construction details are available upon request.
Establishment of stable C3H10-Runx2-kd and C3H10-PPARγ2-kd lines
As the pSOS is a retrovirus-based vector, we pooled the three pSOS-simRunx2 or pSOS-simPPARγ2 plasmids and packaged retroviral viruses by transfecting HEK-293 cells with the packaging plasmid pAmpho [52] . The produced retroviral supernatants were used to infect subconfl uent C3H10T1/2 cells (e.g., usually 3-4 rounds of infection within 24-36 h). The infected cells were selected against blasticidin S (Invitrogen) for 5-7 days. The empty pSOS vector was used to establish a control stable line. The stable lines were designated as C3H10-Runx-kd, C3H10-PPARγ2, and C3H10-Control.
PPARγ2 null mouse embryonic fi broblasts (MEFs)
MEFs derived from animals with the homozygous and heterozygous deletion of PPARγ2 (i.e., MEF-PPARγ2
-/-and MEF-PPARγ2 
Immunofl uorescence staining
Immunofl uorescence staining was carried out as described [31, 32] . Briefl y, subconfl uent C3H10-Runx-kd and C3H10-Control cells were fi xed with methanol at -20°C for 15 min and washed with PBS. The fi xed cells were permeabilized, blocked with 10% goat serum, and followed by incubation with anti-Runx2 antibody. After washing, the cells were incubated with anti-mouse IgG secondary antibody labeled with Alexa Fluor 594 (Molecular Probes). The presence of Runx2 protein was examined under a fl uorescence microscope. Stains without the primary antibody, or with control IgG, were used as negative controls.
Stem cell implantation
The use and care of animals were approved by the Institutional Animal Care and Use Committee. Subconfl uent C3H10T1/2, its derivative lines, or MEFs were infected with AdBMPs, AdGFP, and/or AdPPARγ2 or AdRunx2 for 15 h, and collected for subcutaneous injection (5 × 10 6 cells per injection) into the fl anks of athymic nude (nu/nu) mice (fi ve animals per group, 4 to 6-week-old, male, Harlan Sprague
BMPs regulate both osteogenic and adipogenic differentiation
The overlapping osteogenic and chondrogenic activities of several BMPs may not be surprising, as chondrogenesis and osteogenesis are closely related and well-coordinated processes during skeletal development. In fact, endochondrondral ossifi cation is the major bone formation process for long bone growth [22] . However, we were intrigued by the strong adipogenic activity of several osteogenic BMPs. Although not well defi ned, it has long been speculated that the disrupted balance between osteogenesis and adipogenesis may be responsible for certain diseases, such as agerelated osteoporosis [55] [56] [57] [58] [59] [60] [61] . We sought to further dissect the osteogenic versus adipogenic activity of the BMPs in MSCs. Consistent with our earlier fi ndings, only BMP-2, -4, -6, -7, and -9 of the 14 BMPs were shown to induce the early osteogenic marker alkaline phosphatase in MSCs ( Fig. 2A) . Under the same conditions, the above fi ve osteogenic BMPs were shown to effectively induce adipogenic differentiation, as assessed with Oil Red-O staining (Fig. 2B ). We also analyzed the expression of the late marker of adipogenic differentiation lipoprotein lipase (LPL) upon BMP stimulation, and found that the fi ve osteogenic BMPs exhibited the greatest ability to induce LPL expression in C3H10T1/2 cells (data not shown). Interestingly, BMP-12, -13, and -14 also exhibited a modest ability to induce terminal adipogenic differentiation, while BMP-5 and BMP-10, although able to induce PPARγ2 expression (Fig. 1D ), did not induce signifi cant Oil Red-O staining under the same assay conditions (Fig. 2B) . Similar results were also obtained using primary MEFs and primary marrow stromal cells, although these progenitor cells exhibited a detectable level of spontaneous differentiation (data not shown).
and gradient-based shading (VolView 2.0: Kitware, Inc) techniques.
Results
BMPs exert distinctive abilities to induce lineage-specifi c regulators of mesenchymal progenitor cells
We previously demonstrated that BMP-2, -6, and -9 are the most potent inducers of osteoblast differentiation [22, [27] [28] [29] [30] [31] [32] . Here, we sought to further determine how the 14 BMPs regulate multilineage commitment and differentiation of MSCs. We focused on four commonly known lineages derived from MSCs, and analyzed the expression of the known respective lineage-specifi c regulators: Runx2 (osteogenic), Sox9 (chondrogenic), PPARγ2 (adipogenic), and MyoD (myogenic). Most BMPs, except BMP-3 and BMP-8, exhibit a modest ability to up-regulate Runx2 expression (Fig. 1A) . These results are intriguing because, although they are consistent with the recent observation that BMP-3 has been shown to inhibit osteogenesis [53] , we and others have demonstrated that only BMP-2, -4, -6, -7, and 9 can induce de novo bone formation [29, 54] . One possibility is that Runx2 is not only associated with osteogenesis. When the expression of chondrogenic regulator Sox9 was examined, we found that osteogenic BMP-2, -4, and -7 signifi cantly induced Sox9 expression, whereas BMP-11, -10, -13, and -14 also up-regulated Sox9 expression (Fig. 1B) . However, most BMPs, except BMP-11 and 15, exhibited a weak ability to induce the expression of the myogenic regulator MyoD under the same conditions (Fig. 1C) . Lastly, we analyzed the expression of the adipogenic regulator PPARγ2 and found that BMP-2, -4, -5, -6, -7, -9, and -10 effectively induced PPARγ2 expression in MSCs (Fig. 1D ). -9, or GFP control [22, 28, 29, 31, 32, 48, 50, 51] . At day 14, cells were fi rst stained for alkaline phosphatase activity, followed by Oil Red-O staining. As shown in Figure 3A , as an early osteogenic marker, alkaline phosphatase staining was still readily detectable in the cells stimulated with all fi ve osteogenic BMPs at day 14. The osteogenic BMP-stimulated C3H10T1/2 cells also exhibited positive
BMP-regulated osteogenic and adipogenic lineage commitment of MSCs is mutually exclusive
We next examined whether MSCs committed to adipogenesis or osteogenesis were derived from distinct cell populations. Briefl y, C3H10T1/2 cells were infected with adenovirus vectors expressing BMP-2, -4, -6, -7, or that these BMPs may not only promote lineage specifi c differentiation but also may be important for the early proliferation and repopulation of the MSCs. Consistent with the in vitro fi ndings, BMP-2 and -9 induced both osteogenesis and adiogenesis, while chondrogenesis was readily detectable in some of these samples, most notably BMP-2-transduced MSC masses. Representative histologic fi ndings from AdBMP-2 and AdBMP-9 infected cell implants are shown in Fig. 4B . Consistent with our earlier fi ndings [29] , these fi ndings indicate that BMP-2 induces predominantly endochondral ossifi cation, while BMP-9 primarily induces intramembraneous ossifi cation. The results were confi rmed when the retrieved MSCs masses were stained with Alcian Blue. A signifi cant number of Alcian Blue-stained positive cells were found in BMP-2-treated MSC implants, whereas a scattered few positive cells were detected in BMP-9-transduced MSC implants (Fig. 4C) . Nevertheless, mature mineralized bone-like matrix was readily found in both BMP-2 and BMP-9-tranduced MSC implants, as demonstrated by Masson's Trichrome staining (Fig. 4D) . Oil Red-O staining revealed that both mature adipocytes and preadipocytes were readily found in BMP-2 or BMP-9-transduced MSC implants (Fig. 4E) . Overall, our results confi rm the in vitro fi ndings, and suggest that some of these BMPs may regulate both osteogenic and adipogenic lineage commitment and terminal differentiation of MSCs.
Overexpression of Runx2 synergizes BMP-induced ALP activity without affecting adipogenic differentiation
We next examined the role of Runx2, a well-established regulator of osteoblast differentiation, in BMP-9-induced MSC differentiation. Using an adenoviral vector expressing Oil Red-O staining. These double staining experiments suggest that the BMP-induced osteogenic and adipogenic lineage commitments of mesenchymal progenitor cells may be mutually exclusive, although the progenitor cells undergoing osteogenic or adipogenic differentiation are closely located and are usually intertwined. These fi ndings were also confi rmed by electron microscope analysis. As shown in Fig. 3B , BMP-2 and BMP-9 effectively induced the cytoplasm membrane-bound ALP activity in certain cells, and lipid accumulation in other cells. It was also noted that the ALP positive cells were metabolically active and highly rich in organelles, such as mitochondria and ER apparatuses. Under this assay condition, we did not observe any cells that exhibited both high ALP activity and lipid accumulation, suggesting that BMP-induced osteogenic and adipogenic lineage commitment is mutually exclusive.
BMPs regulate both osteogenic and adipogenic differentiation of mesenchymal progenitor cells in vivo
We then determined whether BMPs could induce both osteogenic and adipogenic differentiation in vivo. We conducted a series of stem cell transplantation experiments, in which MSCs transduced with AdBMP-2, AdBMP-9, or AdGFP, were injected subcutaneously into athymic nude mice. After 5 weeks, the animals were sacrifi ced for microCT imaging and the implanted cell masses were retrieved for histologic evaluation. While no palpable mass was formed in the animals injected with AdGFP-infected cells, the AdBMP-2 or AdBMP-9-infected cells formed solid cell/tissue masses, and larger masses were found in the animals injected with BMP-9-expressing MSCs (Fig. 4A) . These results suggest 7B ) and histologic evaluation. Abbreviations: Ac, adipocyte; MB, mineralized bone matrix.
Overexpression of PPARγ2 promotes both osteogenic and adipogenic differentiation
The role of PPARγ2 in BMP-induced differentiation of MSCs is rather intriguing. PPARγ2 has been shown to be signifi cantly up-regulated by several BMPs, especially osteogenic BMPs (Fig. 1D) [30] . To examine the role of PPARγ2 in BMP-induced differentiation of MSCs, we used an adenoviral vector to express mouse PPARγ2. As shown in Fig. 5C , overexpression of PPARγ2 enhanced ALP activity by 79%, 63%, and 64% for BMP-2, BMP-6, and BMP-9 stimulated MSCs, respectively. These results were also confi rmed Runx2, we found that overexpression of Runx2 in C3H10T1/2 cells resulted in approximately 140%, 190%, and 170% increase in ALP activity upon BMP-2, BMP-6, and BMP-9 stimulation, respectively (Fig. 5A) . Similar results were obtained for ALP histochemical staining assays ( Supplementary Fig.  3A ) (Supplementary Fig. 3 is available online at http://www. liebertpub.com/scd). However, overexpression of Runx2 did not inhibit, if not increase the adipogenic differentiation of MSCs stimulated by BMP-2, -6, and -9 (Fig. 5B) . These fi ndings suggest that Runx2 may primarily regulate osteogenic differentiation of MSCs without affecting adipogenic differentiation.
evaluation revealed that osteoid matrix and not fully mineralized bone matrix were readily detected in the samples retrieved from either Runx2 or PPARγ2 knockdown MSC implantation (Fig. 7B) . These results were reproducible in three batches of independent experiments. In the Runx2 knockdown samples, there was also a decrease in adipocyte accumulation. Noticeable decrease in adipocyte accumulation was obtained in PPARγ2 knockdown samples. These in vivo results were in general consistent with that of the in vitro fi ndings shown in Figs. 5 and 6. Our fi ndings strongly suggest that PPARγ2, in addition to its critical role in adipogenic differentiation, may play a role in regulating BMP-9-induced terminal differentiation of osteogenic progenitor cells.
Deletion of PPARγ2 results in decreased ossifi cation of BMP-9-stimulated PPARγ2
-/-MEFs Considering a possible partial phenotype of RNAi knockdown of PPARγ2 in C3H10T1/2 cells, we used the MEFs derived from animals in which the PPARγ2 was genetically deleted and investigated that the loss of PPARγ2 would affect BMP-9-induced bone formation. The relative PPARγ2 expression was analyzed in PPARγ2 heterozygous and homozygous MEFs, and confi rmed that PPARγ2 level was low in PPARγ2 homozygous MEFs (Fig. 7C) . The ALP activity was slightly decreased in PPARγ2 null MEFs upon BMP-9 stimulation, while as expected the adipogenic differentiation was notably decreased in PPARγ2 null MEFs upon BMP-9 stimulation (Fig. 7D) . Stem cell implantation experiments revealed that PPARγ2 null MEFs formed smaller palpable masses than that of the wildtype or heterozygous MEFs (data not shown), whereas much low or no detectable ossifi ed masses were observed with microCT imaging analysis in PPARγ2 MEFs injected the animals (Fig. 7E) . Histologically, the masses retrieved from PPARγ2 null MEF implantation displayed a feature of more immature or nonmineralized osteoid matrix containing chondrocytes (Fig.  7F) . As expected, no signifi cant adipogenic differentiation was observed in PPARγ2 null MEFs derived masses (Fig.  7F) . Thus, the results obtained from PPARγ2 -/-MEFs are consistent with that from the C3H10-PPARγ2-kd cell. Taken together, these fi ndings suggest that PPARγ2 may play an important role in regulating both osteogenic and adipogenic differentiation of MSCs, although the exact mechanism through which PPARγ2 regulates osteocyte and adipocyte lineage commitment and terminal differentiation remains to be elucidated.
Discussion
Using a well-characterized mesenchymal progenitor cell line C3H10T1/2 [47] , we conducted a comprehensive analysis of the 14 types of BMPs for their abilities to regulate multilineage specifi c differentiation of MSCs. Most BMPs exhibited distinct abilities to regulate expression of the master regulators of four common lineages derived from MSCs. When the osteogenic and adipogenic lineages were analyzed, BMP-2, -4, -6, -7, and -9 were shown to effectively induce both adipogenic and osteogenic differentiation of MSCs in vitro and in vivo. However, the BMP-induced commitment to osteogenic or adipogenic lineage was mutually exclusive. Overexpression of Runx2 enhanced by histochemical staining (Supplementary Fig. 3B ). As expected, overexpression of PPARγ2 promoted BMP-induced adipogenic differentiation (Fig. 5D) . The in vivo stem cell implantation experiments confi rmed that overexpression of PPARγ2 promoted both osteogenic and adipogenic differentiation ( Fig. 5E and Fig. 7A panels a and b) . These fi ndings strongly suggest that PPARγ2 may play an important role in regulating BMP-mediated osteogenic and adipogenic lineage commitment of MSCs.
Knockdown of Runx2 or PPARγ2 expression leads to a decrease in BMP-mediated osteogenic differentiation of MSCs
To complement the above overexpression experiments, we sought to further investigate the effect of silencing Runx2 and PPARγ2 on BMP-induced osteogenic and adipogenic differentiation of MSCs. We used our recently developed pSOS system to select and validate the siRNA target sites of mouse Runx2 and PPARγ2 [52] . We chose four candidate siRNA sites that targeted the coding region of mouse Runx2 or PPARγ2 (Supplementary Table 1 ). We demonstrated that three of the four tested siRNA sites effectively silenced GFPRunx2 chimeric transcript in transient transfection assays ( Supplementary Fig. 1A and B) (Supplementary Fig. 1 is available online at http://www.liebertpub.com/scd). We then pooled the pSOS vectors expressing the three effective siRNA sites and established a stable pool of C3H10T1/2 cells, designated as C3H10-Runx2-kd. The effective silencing of Runx2 expression in this stable line was confi rmed by immunofl uorescence staining (Supplementary Fig. 1C ). The siRNA sites targeting the coding region of mouse PPARγ2 were selected and validated in a similar fashion (Supplementary Fig. 2A and B) ( Supplementary Fig. 2 is available online at http:// www.liebertpub.com/scd). The pooled three PPARγ2 siRNA sites were used to establish a stable pool of C3H10T1/2 cells, designated as C3H10-PPARγ2-kd. The knockdown effi ciency (>50%) of C3H10-Runx2-kd and C3H10-PPARγ2-kd was further confi rmed by quantitative real-time PCR assays (Fig. 6A  and C) . Our results demonstrated that silencing either Runx2 or PPARγ2 expression resulted in a decrease in BMP-induced ALP activity. Specifi cally, the ALP activity decreased to approximately 16%, 7%, and 13% for BMP-2, BMP-6, and BMP-9-stimulated C3H10-Runx2-kd cells, respectively, compared to that of the empty vector control line C3H10-Control (Fig. 6B) . Similarly, compared to that of the empty vector control line C3H10-Control, the ALP activity decreased to approximately 21%, 25%, and 19% for BMP-2, BMP-6, and BMP-9-stimulated C3H10-PPARγ2-kd cells, respectively (Fig.  6D) . Similar results were obtained using the histochemical staining assays of ALP activity ( Supplementary Fig. 3C  and D) . On the contrary, the knockdown of either Runx2 or PPARγ2 expression in MSC C3H10T1/2 cells did not significantly affect adipogenic differentiation in vitro, as judged by Oil Red-O staining ( Fig. 6E and F) .
We next performed stem cell implantation experiments to investigate the in vivo effect of silencing Runx2 or PPARγ2 expression on BMP-9-induced bone and fat formation in MSCs. The micoCT imaging demonstrated that knockdown of either Runx2 or PPARγ2 expression in MSCs resulted in the formation of smaller heterotopically ossifi ed masses (Fig. 7A, panel a, vs. panels c and d) . Histologic hypothesized that osteoblast and marrow adipocyte lineages may have a close but reciprocal relationship [61] . Changes in the balance between osteogenesis and adipogenesis have been postulated as contributing factors to physiologic and pathologic conditions, such as ageing and osteoporosis [55] [56] [57] [58] [59] [60] [61] [62] . A recent study indicated that aging activates adipogenic and suppresses osteogenic programs in marrow stem cells [62] . A decrease in bone volume in age-related osteoporosis is usually accompanied by an increase in marrow adipose tissue [55] [56] [57] [58] [59] 60] . PPARγ insuffi ciency was shown to enhance osteogenesis [63] , whereas the PPARγ agonist Rosiglitazone causes bone loss in mice [64, 65] . Conversely, patients with progressive osseous hyperplasia have heterotopic bone formation within adipose tissue [66] . However, Runx2 null mice BMP-induced osteogenic differentiation, whereas knockdown of Runx2 expression diminished BMP-induced bone formation. Changes in the Runx2 expression status did not signifi cantly affect BMP-induced adipogenic differentiation in vitro, although there was a slight decrease in adipocyte accumulation in Runx2 knockdown MSC-formed ectopic bone masses. However, overexpression of PPARγ2 promoted both osteogenic and adipogenic differentiation upon BMP-2, -6 and -9 stimulation. Conversely, both knockdown and deletion of PPARγ2 not only reduced adipogenic differentiation but also signifi cantly inhibited osteogenic differentiation, especially the full mineralization of osteoid matrix.
The ability of PPARγ2 to enhance BMP-induced osteogenic differentiation is rather intriguing. It has long been exhibited impaired bone formation and reduced adipogenesis [67] , suggesting that osteogenic and adipogenic differentiation is closely related. Thus, the possible role of PPARγ2 in BMP-induced osteogenic and adipogenic differentiation of MSCs remains to be defi ned. Our earlier studies indicate that PPARγ2 is readily up-regulated by osteogenic BMPs in preosteoblast progenitor cells [30] , as well as in this study (Fig. 1D) . We also demonstrated that PPARγ2 agonist
Troglitazone inhibited osteogenic BMP-induced ALP activity in MSCs ( Supplementary Fig. 3E and F [16, 22, 23, 27] , little is known about the role of BMP signaling in adipose development. A recent study reported that mice lacking the BMP-2 regulated zinc fi nger protein Schnurri-2 exhibited a signifi cant reduction of in white fat mass [68] . Although several transcription factors have been identifi ed as the "master regulators" of muscle, adipose, bone and cartilage differentiation [4, 5] , the molecular mechanisms which control the early stages of MSC lineage commitment and possible lineage plasticity remain to be understood.
MSC precursors have been shown to be highly heterogeneous in terms of their multilineage differentiation potential or "plasticity" [3, 69] . In fact, only about 30% of the initial adherent bone marrow-derived MSC clones are pluripotent (mostly tri-lineage, osteo/chondo/adipogenic) [3, 69] , and the reminder displays a bi-lineage (osteo/chondrogenic) or uni-lineage (osteogenic) potential [69, 70] . Nevertheless, MSCs can be rather easily isolated from bone marrow and expanded in vitro, and they have generated a great deal of interest and become a prime target for researchers of tissue regeneration and replacement of damaged tissues, such as bone, cartilage, tendon, and ligament [3, 7, 8] .
Future investigations should be directed toward understanding how lineage commitment and divergence of MSCs is regulated [15, 27, 71] . Due to their low frequency and the lack of knowledge on cell surface markers and their location of origin, most information concerning MSCs is derived from in vitro studies. The cell populations could also represent different points of a hierarchy or a continuum of MSC differentiation. These issues reinforce the urgent need for a more comprehensive analysis of the MSC identity and characteristics, which should help to understand the regulatory mechanisms behind lineage determination and terminal differentiation of MSCs. Ultimately, understanding the regulatory mechanisms behind BMP-regulated lineage divergence during MSC differentiation should aid us in understanding the causes of skeletal diseases (such as osteoporosis and obesity) and may lead to the development of novel therapeutic strategies for regenerative medicine.
